by clearskymd | Dec 16, 2020 | Parkinson's
Essential tremor (ET) is a neurological disorder that causes involuntary and rhythmic shaking. It is estimated that up to six per cent of the UK has essential tremor and it is eight times more common than Parkinson’s. Yet it is one of the conditions most easily...
by clearskymd | Dec 14, 2020 | Company News
Professor Stephen Smith highlighted the work of ClearSky Medical Diagnostics in diagnosing and monitoring Parkinson’s at a UK–China university consortium in November. The UK-Jiangsu World-Class University Consortium is a group of more than 30 leading...
by clearskymd | Nov 16, 2020 | Company News
ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s. Statins, such as Simvastatin, are a group of medicines that are currently prescribed to lower cholesterol in the blood....
by clearskymd | Sep 24, 2020 | Company News
ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology. Data science company StartUs Insights, which identifies startups, disruptive technologies and new business models early-on, selected...
by clearskymd | Jul 7, 2020 | Company News
We have launched a new study in China to establish introducing bradykinesia as a feature being measured by LID-Monitor. Parkinson’s is the second most common neurodegenerative disorder and is characterised by bradykinesia – a slowness in carrying out movements....
Recent Comments